Patent · US Active

Therapeutic derivatives of interleukin-22

US12226487B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2024
Grant dateFeb 18, 2025
Priority date
Expiry dateApr 5, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.